We found for
Working Towards a Sustainable, Healthy Market for Vaccines: a Comprehensive Framework to Support Policy Dialogue and Decision-Making
![FINAL_OHE HVMF White Paper 2021_for posting 2-01](https://www.ohe.org/wp-content/uploads/2021/11/FINAL_OHE-HVMF-White-Paper-2021_for-posting-2-01.png)
Key Factors on How to Procure, Pay, Distribute and Use Vaccines for COVID-19: A European Perspective
![Key Factors on How to Procure, Pay and use Vaccines for COVID-19 2-01](https://www.ohe.org/wp-content/uploads/2021/11/Key-Factors-on-How-to-Procure-Pay-and-use-Vaccines-for-COVID-19-2-01.png)
Cornerstones of “Fair” Drug Coverage: Appropriate Cost – Sharing and Utilization Management Policies for Pharmaceuticals
![Cornerstones of “Fair” Drug Coverage: Appropriate Cost - Sharing and Utilization Management Policies for Pharmaceuticals](https://www.ohe.org/wp-content/uploads/2020/09/Font-Cover.jpg)
The Case of Risperidone: Assessing the Life-cycle Value of Second-Generation Antipsychotics in Sweden and the UK
![Risperidone Cover Page](https://www.ohe.org/wp-content/uploads/2019/07/Risperidone-Cover-Page.jpg)
Documento de debate sobre la fijación de precios en función de la indicación (IBP) ¿Deben variar los precios de los medicamentos según la indicación?
![IBP Cover](https://www.ohe.org/wp-content/uploads/2019/06/IBP-Cover.jpg)
The WHO Technical Report on the Pricing of Cancer Medicines: Missing a central role for HTA and value assessment
![WHO-cancer-medicines-rebrand](https://www.ohe.org/wp-content/uploads/2019/05/WHO-cancer-medicines-rebrand.png)